Wilsons Disease (WD) Drugs Market by Product, Distribution Channel, and Geography - Forecast and Analysis - 2023-2027

Published: Jul 2023

Pages: 150

SKU: IRTNTR75840

Snapshot

Wilson's Disease (WD) Drugs Market Report 2023-2027:

The global Wilson's disease drugs market size is estimated to grow by USD 179.97 million at a CAGR of 6.32% between 2022 and 2027.

One of the driving factors for the growth of the market is growing awareness among individuals about the treatment of Wilson's disease. Many people come to the clinic complaining of abdominal pain, light-colored stools, dark-colored urine, jaundice, anxiety and depression, disturbed thoughts and emotions, mood swings, corneal limbal rings, muscle stiffness, and tremors, which are the symptoms of Wilson's disease. Various organizations such as Wilson Disease Association and National Organization for Rare Disorders, are raising awareness about Wilson's disease, which will drive Wilson's disease (WD) drugs market growth. Wilson's Disease Association is a volunteer organization based in New York that aims to promote the well-being of patients affected by Wilson's disease by providing up-to-date information on diseases, symptoms, and treatment. In addition, the Wilson Disease Association provides funding for research and trials for Wilson's disease. Thus, increasing awareness of the treatment of Wilson's disease among individuals will drive the growth of the global Wilson's disease drugs market during the forecast period.

Technavio has segmented the market into Products, Distribution channels, and Geography.

The Product segment is classified into chelators and minerals
The distribution channel segment is classified into retail pharmacies, hospital pharmacies, and online pharmacies
The geography segment includes key regions such as (North America, Europe, Asia, and the Rest of the World (ROW))

It also includes an in-depth analysis of drivers, trends, and challenges.

What will be the size of the Wilson's Disease Drugs Market During the Forecast Period?

To learn more about this report, Request Free Sample

Wilson's Disease Drugs Market Segmentation by Product, Distribution Channel, and Geography Analysis

Product Analysis

Chelators segment

The market share growth by the chelators segment will be significant during the forecast period. Copper chelators are the first line of therapy for Wilson's disease, which includes Penicillamine and trientine. Copper chelators work by reducing the copper toxicity in the body, which is then preventing it from reaccumulating on its own. Clovique and synephrine as well as trientine are some of the common or brand names for copper chelators. The growth of the segment is due to the rising incidences of Wilson's disease across all the regions.

Get a glance at the market contribution of various segments View a PDF Sample

The chelators segment was valued at USD 264.85 million in 2017. The pharmaceutical industry and research organizations are concentrating on the discovery of a treatment for Wilson's disease. The ongoing research initiatives undertaken by market leaders like Bausch Recordati and Teva Pharmaceuticals as well as other participants in that market, the deployment of new technologies, in addition to significant government and private sector funding in Wilson's disease research, will drive the growth of the chelators segment.

Distribution Channel segment

Retail pharmacies segment

Based on the distribution channel, the market has been segmented into retail pharmacies, hospital pharmacies, and online pharmacies. The Retail pharmacies segment will account for the largest share of this segment. The retail pharmacies segment of the global Wilson's disease (WD) drugs market includes chain pharmacies, independent pharmacies, and drugstores that dispense prescription and over-the-counter medications to patients outside of a hospital setting. Generally, Wilson's Disease medicinal products are bought in smaller quantities from wholesalers or manufacturers by retail pharmacies. They stock a range of medications used to manage Wilson's disease drugs. Retail pharmacies also provide a range of services that can help support the use of Wilson's disease drugs, such as medication counseling, medication therapy management, and disease management programs. These services may be able to help patients understand their medical condition and how they are being treated, which could lead to better health outcomes and an increase in demand for Wilson's disease medicines. Retail pharmacies play an important role in the distribution of Wilson's disease drugs and can contribute to the growth

Regional Analysis

For more insights about the market share of various regions View PDF Sample now!

North America is estimated to contribute 38% to the growth of the global market during the forecast period. Technavio’s analysts have elaborately explained the regional trends and drivers that will shape the market during the forecast period.

The availability of improved healthcare infrastructure and the presence of reimbursement policies and co-pay assistance programs such as Medicaid and Medicare enable individuals to opt for medical treatment. However, the increasing availability of generics in the market is expected to offset the growth partially. Drug developers are encouraged to explore new treatment options by favorable regulatory initiatives for the approval of Wilson's disease drugs. The US is the major revenue contributor to Wilson's disease (WD) drugs market in the region. Few factors are expected to drive the growth of the regional market during the forecast period.

In 2020, the outbreak of COVID-19 adversely affected the healthcare sector of various countries, such as the US and Canada in the region. However, government initiatives such as mass vaccination drives and other restrictions such as social distancing have helped the regional government to curb the spread of the virus. The lockdowns were lifted and the restrictions were relaxed by the government. The treatment of piled-up cases of Wilson's disease drugs has started, which will further drive the market for regional Wilson's disease drugs during the forecast period.

Buy Now Full Report and Discover More

Key Wilson's Disease Drugs Market Players

Vendors are implementing various strategies, such as strategic alliances, partnerships, mergers and acquisitions, geographical expansion, and product/service launches, to enhance their presence in the market. The report also includes detailed analyses of the competitive landscape of the market and information about 17 market vendors, including:

ANI Pharmaceuticals Inc. - The company offers Wilson's disease drugs such as ANI Pharmaceuticals Cuprimine.

Qualitative and quantitative analysis of vendors has been conducted to help clients understand the wider business environment as well as the strengths and weaknesses of key market players. Data is qualitatively analyzed to categorize vendors as pure play, category-focused, industry-focused, and diversified; it is quantitatively analyzed to categorize vendors as dominant, leading, strong, tentative, and weak.

Wilson's Disease Drugs Market: Key Trends, Challenges, and Customer Landscape

There are multiple factors influencing market growth. Our researchers analyzed the data with 2022 as the base year, along with the key trends and challenges.

Significant Wilson's Disease Drugs Market Trends

The growing prevalence of chronic pain is a primary trend in Wilson's disease drug market. The demand for Wilson's disease medicines is increasing due to the increase in chronic pain conditions, such as Wilson's disease. Furthermore, according to data from the National Health Interview Survey (NHIS), the prevalence of chronic pain was 20.4% globally in February 2022, and the prevalence of high-impact chronic pain was 7.4% (or 36.4% of adults with chronic pain).

Globally, women (21.7%), non-Hispanic white adults (23.6%), and those aged 65 and up (30.8%) had the highest rates of chronic pain. Therefore, the global market for Wilson's disease medicinal products will grow over the forecast period due to a growing prevalence of chronic pain.

Major Wilson's Disease Drugs Market Challenges

The stringent regulatory environment on Wilson's drug development and approval is a major challenge faced by Wilson's disease drugs market. In order to guarantee a high level of sterileness and consistency, the majority of pharmaceutical development and approval processes are strictly regulated by different regulatory authorities. The key factors examined by these regulatory bodies include safety, efficacy, medicinal product information, pharmacodynamic effects, and interactions. Therefore, if a drug fails to comply with any of these criteria, it is likely to receive a complete response letter (CRL) or may face complete rejection from regulatory agencies. On receiving a CRL, a drug applicant (pharma company) needs to furnish additional data pertaining to the drug. This may require further studies for the drug applicant, leading to increased spending on research and development. In some cases, drug applicants withdraw their applications and discontinue their drug candidates.

Clinical trials for a drug are typically done in three phases. The US Food and Drug Administration may require further information or suspend the current study if any serious safety, efficacy, or tolerability problems are observed in all phases of animal studies or trials. Upon successful completion of all three phases of clinical trials, the applicant is required to submit a new drug application (NDA) to the US FDA. Such stringent regulatory guidelines on Wilson's drug development and approval can hamper the growth of the market during the forecast period.

Buy Now Full Report and Discover More

Key Wilson's Disease Drugs Market Customer Landscape

The market report includes the adoption lifecycle of the market, covering from the innovator’s stage to the laggard’s stage. It focuses on adoption rates in different regions based on penetration. Furthermore, the report also includes key purchase criteria and drivers of price sensitivity to help companies evaluate and develop their growth strategies.

Global Wilson's Disease Drugs Market Customer Landscape

Segment Overview

The Wilson's disease drugs market report forecasts market growth by revenue at global, regional & country levels and provides an analysis of the latest trends and growth opportunities from 2017 to 2027.

Product Outlook (USD Million, 2017 - 2027)
- Chelators
- Minerals

Distribution Channel Outlook (USD Million, 2017 - 2027)
- Retail pharmacies
- Hospital pharmacies
- Online pharmacies

Region Outlook (USD Million, 2017 - 2027)
- North America
  - The U.S.
  - Canada
- Europe
  - The U.K.
  - Germany
  - France
  - Rest of Europe
- Asia
  - China
  - India
- ROW
  - Australia
  - Argentina
  - Rest of the World

Wilson's Disease Drugs Market Scope
Report Coverage	Details
Page number	150
Base year	2022
Historic period	2017-2021
Forecast period	2023-2027
Growth momentum & CAGR	Accelerate at a CAGR of 6.32%
Market growth 2023-2027	USD 179.97 million
Market structure	Fragmented
YoY growth 2022-2023(%)	5.25
Regional analysis	North America, Europe, Asia, and the Rest of the World (ROW)
Performing market contribution	North America at 38%
Key countries	US, Canada, Germany, UK, and China
Competitive landscape	Leading Vendors, Market Positioning of Vendors, Competitive Strategies, and Industry Risks
Key companies profiled	ANI Pharmaceuticals Inc., Apotex Inc., AstraZeneca Plc, Bausch Health Co. Inc., Breckenridge Pharmaceutical Inc., Dr. Reddys Laboratories Ltd., Endo International Plc, Lupin Ltd., Merck and Co. Inc., Navinta LLC, Noblepharma Co. Ltd., Panacea Biotec Ltd., Recordati S.p.A, Sanofi, Taj Pharmaceutical Ltd., Teva Pharmaceutical Industries Ltd., and Tsumura and Co.
Market dynamics	Parent market analysis, Market growth inducers and obstacles, Fast-growing and slow-growing segment analysis, COVID-19 impact and recovery analysis and future consumer dynamics, and Market condition analysis for the forecast period.
Customization purview	If our report has not included the data that you are looking for, you can reach out to our analysts and get segments customized.

View Sample PDF at your Fingertips

What are the Key Data Covered in this Wilson's Disease Drugs Market Research Report?

CAGR of the market during the forecast period
Detailed information on factors that will drive the growth of Wilson's disease drugs market between 2023 and 2027
Precise estimation of the market in focus on the parent market
Detailed analysis of customer landscape covering Diver of price sensitivity, Adoption of the lifecycle, and key purchase criteria
Vendor landscape comparing criticality of inputs and factors of differentiation
Exclusive Matrix on vendor position and Classification
Accurate predictions about upcoming trends and changes in consumer behavior
Growth of the market industry across North America, Europe, Asia, and the Rest of the World (ROW)
A thorough analysis of the market’s competitive landscape and detailed information about vendors
Comprehensive analysis of factors that will challenge the growth of Wilson's disease drugs market vendors

We can help! Our analysts can customize this market research report to meet your requirements. Get in touch

Table of Contents

1 Executive Summary

1.1 Market overview
- Exhibit 01: Executive Summary – Chart on Market Overview
- Exhibit 02: Executive Summary – Data Table on Market Overview
- Exhibit 03: Executive Summary – Chart on Global Market Characteristics
- Exhibit 04: Executive Summary – Chart on Market by Geography
- Exhibit 05: Executive Summary – Chart on Market Segmentation by Product
- Exhibit 06: Executive Summary – Chart on Market Segmentation by Distribution Channel
- Exhibit 07: Executive Summary – Chart on Incremental Growth
- Exhibit 08: Executive Summary – Data Table on Incremental Growth
- Exhibit 09: Executive Summary – Chart on Vendor Market Positioning

2 Market Landscape

2.1 Market ecosystem
- Exhibit 10: Parent market
- Exhibit 11: Market Characteristics

3 Market Sizing

3.1 Market definition
- Exhibit 12: Offerings of vendors included in the market definition

3.2 Market segment analysis
- Exhibit 13: Market segments

3.3 Market size 2022

3.4 Market outlook: Forecast for 2022-2027
- Exhibit 14: Chart on Global - Market size and forecast 2022-2027 ($ million)
- Exhibit 15: Data Table on Global - Market size and forecast 2022-2027 ($ million)
- Exhibit 16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
- Exhibit 17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)

4 Historic Market Size

4.1 Global wilsons disease drugs market 2017 - 2021
- Exhibit 18: Historic Market Size – Data Table on global wilsons disease drugs market 2017 - 2021 ($ million)

4.2 Product Segment Analysis 2017 - 2021
- Exhibit 19: Historic Market Size – Product Segment 2017 - 2021 ($ million)

4.3 Distribution Channel Segment Analysis 2017 - 2021
- Exhibit 20: Historic Market Size – Distribution Channel Segment 2017 - 2021 ($ million)

4.4 Geography Segment Analysis 2017 - 2021
- Exhibit 21: Historic Market Size – Geography Segment 2017 - 2021 ($ million)

4.5 Country Segment Analysis 2017 - 2021
- Exhibit 22: Historic Market Size – Country Segment 2017 - 2021 ($ million)

5 Five Forces Analysis

5.1 Five forces summary
- Exhibit 23: Five forces analysis - Comparison between 2022 and 2027

5.2 Bargaining power of buyers
- Exhibit 24: Chart on Bargaining power of buyers – Impact of key factors 2022 and 2027

5.3 Bargaining power of suppliers
- Exhibit 25: Bargaining power of suppliers – Impact of key factors in 2022 and 2027

5.4 Threat of new entrants
- Exhibit 26: Threat of new entrants – Impact of key factors in 2022 and 2027

5.5 Threat of substitutes
- Exhibit 27: Threat of substitutes – Impact of key factors in 2022 and 2027

5.6 Threat of rivalry
- Exhibit 28: Threat of rivalry – Impact of key factors in 2022 and 2027

5.7 Market condition
- Exhibit 29: Chart on Market condition - Five forces 2022 and 2027

6 Market Segmentation by Product

6.1 Market segments
- Exhibit 30: Chart on Product - Market share 2022-2027 (%)
- Exhibit 31: Data Table on Product - Market share 2022-2027 (%)

6.2 Comparison by Product
- Exhibit 32: Chart on Comparison by Product
- Exhibit 33: Data Table on Comparison by Product

6.3 Chelators - Market size and forecast 2022-2027
- Exhibit 34: Chart on Chelators - Market size and forecast 2022-2027 ($ million)
- Exhibit 35: Data Table on Chelators - Market size and forecast 2022-2027 ($ million)
- Exhibit 36: Chart on Chelators - Year-over-year growth 2022-2027 (%)
- Exhibit 37: Data Table on Chelators - Year-over-year growth 2022-2027 (%)

6.4 Minerals - Market size and forecast 2022-2027
- Exhibit 38: Chart on Minerals - Market size and forecast 2022-2027 ($ million)
- Exhibit 39: Data Table on Minerals - Market size and forecast 2022-2027 ($ million)
- Exhibit 40: Chart on Minerals - Year-over-year growth 2022-2027 (%)
- Exhibit 41: Data Table on Minerals - Year-over-year growth 2022-2027 (%)

6.5 Market opportunity by Product
- Exhibit 42: Market opportunity by Product ($ million)
- Exhibit 43: Data Table on Market opportunity by Product ($ million)

7 Market Segmentation by Distribution Channel

7.1 Market segments
- Exhibit 44: Chart on Distribution Channel - Market share 2022-2027 (%)
- Exhibit 45: Data Table on Distribution Channel - Market share 2022-2027 (%)

7.2 Comparison by Distribution Channel
- Exhibit 46: Chart on Comparison by Distribution Channel
- Exhibit 47: Data Table on Comparison by Distribution Channel

7.3 Retail pharmacies - Market size and forecast 2022-2027
- Exhibit 48: Chart on Retail pharmacies - Market size and forecast 2022-2027 ($ million)
- Exhibit 49: Data Table on Retail pharmacies - Market size and forecast 2022-2027 ($ million)
- Exhibit 50: Chart on Retail pharmacies - Year-over-year growth 2022-2027 (%)
- Exhibit 51: Data Table on Retail pharmacies - Year-over-year growth 2022-2027 (%)

7.4 Hospital pharmacies - Market size and forecast 2022-2027
- Exhibit 52: Chart on Hospital pharmacies - Market size and forecast 2022-2027 ($ million)
- Exhibit 53: Data Table on Hospital pharmacies - Market size and forecast 2022-2027 ($ million)
- Exhibit 54: Chart on Hospital pharmacies - Year-over-year growth 2022-2027 (%)
- Exhibit 55: Data Table on Hospital pharmacies - Year-over-year growth 2022-2027 (%)

7.5 Online pharmacies - Market size and forecast 2022-2027
- Exhibit 56: Chart on Online pharmacies - Market size and forecast 2022-2027 ($ million)
- Exhibit 57: Data Table on Online pharmacies - Market size and forecast 2022-2027 ($ million)
- Exhibit 58: Chart on Online pharmacies - Year-over-year growth 2022-2027 (%)
- Exhibit 59: Data Table on Online pharmacies - Year-over-year growth 2022-2027 (%)

7.6 Market opportunity by Distribution Channel
- Exhibit 60: Market opportunity by Distribution Channel ($ million)
- Exhibit 61: Data Table on Market opportunity by Distribution Channel ($ million)

8 Customer Landscape

8.1 Customer landscape overview
- Exhibit 62: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

9 Geographic Landscape

9.1 Geographic segmentation
- Exhibit 63: Chart on Market share by geography 2022-2027 (%)
- Exhibit 64: Data Table on Market share by geography 2022-2027 (%)

9.2 Geographic comparison
- Exhibit 65: Chart on Geographic comparison
- Exhibit 66: Data Table on Geographic comparison

9.3 North America - Market size and forecast 2022-2027
- Exhibit 67: Chart on North America - Market size and forecast 2022-2027 ($ million)
- Exhibit 68: Data Table on North America - Market size and forecast 2022-2027 ($ million)
- Exhibit 69: Chart on North America - Year-over-year growth 2022-2027 (%)
- Exhibit 70: Data Table on North America - Year-over-year growth 2022-2027 (%)

9.4 Europe - Market size and forecast 2022-2027
- Exhibit 71: Chart on Europe - Market size and forecast 2022-2027 ($ million)
- Exhibit 72: Data Table on Europe - Market size and forecast 2022-2027 ($ million)
- Exhibit 73: Chart on Europe - Year-over-year growth 2022-2027 (%)
- Exhibit 74: Data Table on Europe - Year-over-year growth 2022-2027 (%)

9.5 Asia - Market size and forecast 2022-2027
- Exhibit 75: Chart on Asia - Market size and forecast 2022-2027 ($ million)
- Exhibit 76: Data Table on Asia - Market size and forecast 2022-2027 ($ million)
- Exhibit 77: Chart on Asia - Year-over-year growth 2022-2027 (%)
- Exhibit 78: Data Table on Asia - Year-over-year growth 2022-2027 (%)

9.6 Rest of World (ROW) - Market size and forecast 2022-2027
- Exhibit 79: Chart on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
- Exhibit 80: Data Table on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
- Exhibit 81: Chart on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
- Exhibit 82: Data Table on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)

9.7 US - Market size and forecast 2022-2027
- Exhibit 83: Chart on US - Market size and forecast 2022-2027 ($ million)
- Exhibit 84: Data Table on US - Market size and forecast 2022-2027 ($ million)
- Exhibit 85: Chart on US - Year-over-year growth 2022-2027 (%)
- Exhibit 86: Data Table on US - Year-over-year growth 2022-2027 (%)

9.8 Germany - Market size and forecast 2022-2027
- Exhibit 87: Chart on Germany - Market size and forecast 2022-2027 ($ million)
- Exhibit 88: Data Table on Germany - Market size and forecast 2022-2027 ($ million)
- Exhibit 89: Chart on Germany - Year-over-year growth 2022-2027 (%)
- Exhibit 90: Data Table on Germany - Year-over-year growth 2022-2027 (%)

9.9 UK - Market size and forecast 2022-2027
- Exhibit 91: Chart on UK - Market size and forecast 2022-2027 ($ million)
- Exhibit 92: Data Table on UK - Market size and forecast 2022-2027 ($ million)
- Exhibit 93: Chart on UK - Year-over-year growth 2022-2027 (%)
- Exhibit 94: Data Table on UK - Year-over-year growth 2022-2027 (%)

9.10 Canada - Market size and forecast 2022-2027
- Exhibit 95: Chart on Canada - Market size and forecast 2022-2027 ($ million)
- Exhibit 96: Data Table on Canada - Market size and forecast 2022-2027 ($ million)
- Exhibit 97: Chart on Canada - Year-over-year growth 2022-2027 (%)
- Exhibit 98: Data Table on Canada - Year-over-year growth 2022-2027 (%)

9.11 China - Market size and forecast 2022-2027
- Exhibit 99: Chart on China - Market size and forecast 2022-2027 ($ million)
- Exhibit 100: Data Table on China - Market size and forecast 2022-2027 ($ million)
- Exhibit 101: Chart on China - Year-over-year growth 2022-2027 (%)
- Exhibit 102: Data Table on China - Year-over-year growth 2022-2027 (%)

9.12 Market opportunity by geography
- Exhibit 103: Market opportunity by geography ($ million)
- Exhibit 104: Data Tables on Market opportunity by geography ($ million)

10 Drivers, Challenges, and Trends

10.1 Market drivers

10.2 Market challenges

10.3 Impact of drivers and challenges
- Exhibit 105: Impact of drivers and challenges in 2022 and 2027

10.4 Market trends

11 Vendor Landscape

11.1 Overview

11.2 Vendor landscape
- Exhibit 106: Overview on Criticality of inputs and Factors of differentiation

11.3 Landscape disruption
- Exhibit 107: Overview on factors of disruption

11.4 Industry risks
- Exhibit 108: Impact of key risks on business

12 Vendor Analysis

12.1 Vendors covered
- Exhibit 109: Vendors covered

12.2 Market positioning of vendors
- Exhibit 110: Matrix on vendor position and classification

12.3 ANI Pharmaceuticals Inc.
- Exhibit 111: ANI Pharmaceuticals Inc. - Overview
- Exhibit 112: ANI Pharmaceuticals Inc. - Product / Service
- Exhibit 113: ANI Pharmaceuticals Inc. - Key offerings

12.4 Apotex Inc.
- Exhibit 114: Apotex Inc. - Overview
- Exhibit 115: Apotex Inc. - Product / Service
- Exhibit 116: Apotex Inc. - Key offerings

12.5 AstraZeneca Plc
- Exhibit 117: AstraZeneca Plc - Overview
- Exhibit 118: AstraZeneca Plc - Product / Service
- Exhibit 119: AstraZeneca Plc - Key news
- Exhibit 120: AstraZeneca Plc - Key offerings

12.6 Bausch Health Co. Inc.
- Exhibit 121: Bausch Health Co. Inc. - Overview
- Exhibit 122: Bausch Health Co. Inc. - Business segments
- Exhibit 123: Bausch Health Co. Inc. - Key news
- Exhibit 124: Bausch Health Co. Inc. - Key offerings
- Exhibit 125: Bausch Health Co. Inc. - Segment focus

12.7 Breckenridge Pharmaceutical Inc.
- Exhibit 126: Breckenridge Pharmaceutical Inc. - Overview
- Exhibit 127: Breckenridge Pharmaceutical Inc. - Product / Service
- Exhibit 128: Breckenridge Pharmaceutical Inc. - Key offerings

12.8 Dr Reddys Laboratories Ltd.
- Exhibit 129: Dr Reddys Laboratories Ltd. - Overview
- Exhibit 130: Dr Reddys Laboratories Ltd. - Business segments
- Exhibit 131: Dr Reddys Laboratories Ltd. - Key offerings
- Exhibit 132: Dr Reddys Laboratories Ltd. - Segment focus

12.9 Endo International Plc
- Exhibit 133: Endo International Plc - Overview
- Exhibit 134: Endo International Plc - Business segments
- Exhibit 135: Endo International Plc - Key news
- Exhibit 136: Endo International Plc - Key offerings
- Exhibit 137: Endo International Plc - Segment focus

12.10 Lupin Ltd.
- Exhibit 138: Lupin Ltd. - Overview
- Exhibit 139: Lupin Ltd. - Product / Service
- Exhibit 140: Lupin Ltd. - Key news
- Exhibit 141: Lupin Ltd. - Key offerings

12.11 Merck and Co. Inc.
- Exhibit 142: Merck and Co. Inc. - Overview
- Exhibit 143: Merck and Co. Inc. - Business segments
- Exhibit 144: Merck and Co. Inc. - Key news
- Exhibit 145: Merck and Co. Inc. - Key offerings
- Exhibit 146: Merck and Co. Inc. - Segment focus

12.12 Navinta LLC
- Exhibit 147: Navinta LLC - Overview
- Exhibit 148: Navinta LLC - Product / Service
- Exhibit 149: Navinta LLC - Key offerings

12.13 Panacea Biotec Ltd.
- Exhibit 150: Panacea Biotec Ltd. - Overview
- Exhibit 151: Panacea Biotec Ltd. - Product / Service
- Exhibit 152: Panacea Biotec Ltd. - Key offerings

12.14 Recordati S.p.A
- Exhibit 153: Recordati S.p.A - Overview
- Exhibit 154: Recordati S.p.A - Business segments
- Exhibit 155: Recordati S.p.A - Key offerings
- Exhibit 156: Recordati S.p.A - Segment focus

12.15 Taj Pharmaceutical Ltd.
- Exhibit 157: Taj Pharmaceutical Ltd. - Overview
- Exhibit 158: Taj Pharmaceutical Ltd. - Product / Service
- Exhibit 159: Taj Pharmaceutical Ltd. - Key offerings

12.16 Teva Pharmaceutical Industries Ltd.
- Exhibit 160: Teva Pharmaceutical Industries Ltd. - Overview
- Exhibit 161: Teva Pharmaceutical Industries Ltd. - Business segments
- Exhibit 162: Teva Pharmaceutical Industries Ltd. - Key news
- Exhibit 163: Teva Pharmaceutical Industries Ltd. - Key offerings
- Exhibit 164: Teva Pharmaceutical Industries Ltd. - Segment focus

12.17 Tsumura and Co.
- Exhibit 165: Tsumura and Co. - Overview
- Exhibit 166: Tsumura and Co. - Product / Service
- Exhibit 167: Tsumura and Co. - Key offerings

13 Appendix

13.1 Scope of the report

13.2 Inclusions and exclusions checklist
- Exhibit 168: Inclusions checklist
- Exhibit 169: Exclusions checklist

13.3 Currency conversion rates for US$
- Exhibit 170: Currency conversion rates for US$

13.4 Research methodology
- Exhibit 171: Research methodology
- Exhibit 172: Validation techniques employed for market sizing
- Exhibit 173: Information sources

13.5 List of abbreviations
- Exhibit 174: List of abbreviations

Methodology

Research Framework

Technavio presents a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources. The analysts have presented the various facets of the market with a particular focus on identifying the key industry influencers. The data thus presented is comprehensive, reliable, and the result of extensive research, both primary and secondary.

INFORMATION SOURCES

Primary sources

Manufacturers and suppliers
Channel partners
Industry experts
Strategic decision makers

Secondary sources

Industry journals and periodicals
Government data
Financial reports of key industry players
Historical data
Press releases

DATA ANALYSIS

Data Synthesis

Collation of data
Estimation of key figures
Analysis of derived insights

Data Validation

Triangulation with data models
Reference against proprietary databases
Corroboration with industry experts

REPORT WRITING

Qualitative

Market drivers
Market challenges
Market trends
Five forces analysis

Quantitative

Market size and forecast
Market segmentation
Geographical insights
Competitive landscape

Purchase Report

PURCHASE FULL REPORT OF

wilson's disease drugs market

Buy Report - Single User License 2500 USD

QUICK BUY

Key Questions Answered

What are the key global market and the regional market share?
What are the revenue-generating key market segments?
What are the key factors driving and challenging this market’s growth?
Who are the key market vendors and their growth strategies?
What are the latest trends influencing the growth of this market?
What are the variables influencing the market growth in the primary regions?
What are the factors influencing the growth of the parent market?

Why should you prefer Technavio's market insights report?

Off-the-shelf research reports
Reports can be tailored to meet the customer's needs
Trusted by more than 100 fortune 500 organizations
Information about the market's key drivers, trends, and challenges
Parent market analysis
Every week, 50,000 people visit our subscription platform
Detailed vendors report with competitive landscape
Covid-19 impact and recovery analysis
Data on revenue-generating market segments
Details on the market shares of various regions
Five-force market analysis